RVTY Earnings

RVTY reported its earnings on 2026-02-02, showcasing a revenue of 772.06M against an estimate of 767.20M, resulting in a 0.63% surprise. The EPS was 1.7, surpassing the expected 1.59 by 6.92%. The stock experienced a -1.57% price change on the earnings day and a -8.53% change over the next five days, reflecting market reactions to the results.

Following RVTY's earnings announcement on 2026-02-02, the stock price moved by -1.57% on the day of the release. Over the subsequent five days, it saw a -8.53% change. Historically, RVTY's stock price tends to shift by an average of 0.25% in the 10 days leading up to earnings and -5.36% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate RVTY's annual revenue to reach 681.57M, while the EPS is projected at 1.11. These estimates reflect recent revisions, with revenue estimates revised downward by -0.01% and EPS estimates revised downward by -0.04% over the past three months, indicating analyst expectation in the company's performance.

The correlation between RVTY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.01%, while EPS estimates moved revised downward by -0.04%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, RVTY's stock price typically moves by 0.25% in the 10 days before its earnings and -5.36% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.11 and revenue of 681.57M.

The earnings call highlights strategic partnerships, AI-driven product development, and raised EPS guidance, which are positive indicators. The Q&A section reveals cautious optimism in biotech funding and consistent order trends. Despite a conservative approach to Diagnostics and China IDX, strong free cash flow conversion and a robust software pipeline suggest potential growth. The company's proactive strategies and positive guidance adjustments outweigh concerns, indicating a likely stock price increase.